Literature DB >> 10435638

Cell cycle arrest and morphological alterations following microinjection of NIH3T3 cells with Pur alpha.

D W Stacey1, M Hitomi, M Kanovsky, L Gan, E M Johnson.   

Abstract

Levels of Pur alpha, a protein implicated in control of both DNA replication and gene transcription, fluctuate during the cell cycle, being lowest in early S phase and highest just after mitosis. Here we have employed a new video time-lapse technique enabling us to determine the cell cycle position of each cell in an asynchronous culture at a given time and to ask whether introduction of Pur alpha protein at specific times can affect cell cycle progression. Approximately 80% of all NIH3T3 cells injected with Pur alpha were inhibited from passing through mitosis. Cells injected with Pur alpha during S or G2 phases were efficiently blocked with a 4N (G2 phase) DNA level, as determined by quantitative DNA photometry of individual cells. Of the cells injected with Pur alpha during G1 phase, 40% experienced a rapid cell death characterized by extreme cellular fragmentation. Of those G1 injected cells which remained viable, approximately equal numbers were arrested with either 2N or 4N DNA levels. Cells arrested by Pur alpha in G2 phase grew to cover a large surface area. These results link fluctuations in Pur alpha levels to aspects of cell cycle control.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10435638     DOI: 10.1038/sj.onc.1202795

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Influence of cell cycle and oncogene activity upon topoisomerase IIalpha expression and drug toxicity.

Authors:  D W Stacey; M Hitomi; G Chen
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 2.  PURA, the gene encoding Pur-alpha, member of an ancient nucleic acid-binding protein family with mammalian neurological functions.

Authors:  Dianne C Daniel; Edward M Johnson
Journal:  Gene       Date:  2017-12-06       Impact factor: 3.688

3.  Distinct proteins encoded by alternative transcripts of the PURG gene, located contrapodal to WRN on chromosome 8, determined by differential termination/polyadenylation.

Authors:  Hong Liu; Edward M Johnson
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

4.  Regulation of gonadotropin-releasing hormone-1 gene transcription by members of the purine-rich element-binding protein family.

Authors:  Sheng Zhao; Robert J Kelm; Russell D Fernald
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-12-08       Impact factor: 4.310

Review 5.  Puralpha: a multifunctional single-stranded DNA- and RNA-binding protein.

Authors:  G L Gallia; E M Johnson; K Khalili
Journal:  Nucleic Acids Res       Date:  2000-09-01       Impact factor: 16.971

6.  Pur-alpha regulates RhoA developmental expression and downstream signaling.

Authors:  Mamata Mishra; Luis Del Valle; Jessica Otte; Nune Darbinian; Jennifer Gordon
Journal:  J Cell Physiol       Date:  2013-01       Impact factor: 6.384

Review 7.  The pur protein family: genetic and structural features in development and disease.

Authors:  Edward M Johnson; Dianne C Daniel; Jennifer Gordon
Journal:  J Cell Physiol       Date:  2013-05       Impact factor: 6.384

8.  Puralpha is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse.

Authors:  Kamel Khalili; Luis Del Valle; Vandhana Muralidharan; William J Gault; Nune Darbinian; Jessica Otte; Ellen Meier; Edward M Johnson; Dianne C Daniel; Yayoi Kinoshita; Shohreh Amini; Jennifer Gordon
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

Review 9.  Multiple roles for Puralpha in cellular and viral regulation.

Authors:  Martyn K White; Edward M Johnson; Kamel Khalili
Journal:  Cell Cycle       Date:  2009-02-10       Impact factor: 4.534

10.  Protective role of Puralpha to cisplatin.

Authors:  Rafal Kaminski; Armine Darbinyan; Nana Merabova; Satish L Deshmane; Martyn K White; Kamel Khalili
Journal:  Cancer Biol Ther       Date:  2008-12-08       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.